Perrigo Company plc (NYSE:PRGO – Get Free Report) declared a quarterly dividend on Wednesday, February 19th,RTT News reports. Shareholders of record on Friday, March 7th will be paid a dividend of 0.29 per share on Tuesday, March 25th. This represents a $1.16 annualized dividend and a yield of 4.68%. This is a positive change from Perrigo’s previous quarterly dividend of $0.28.
Perrigo has raised its dividend by an average of 4.8% per year over the last three years and has raised its dividend every year for the last 22 years. Perrigo has a payout ratio of 32.7% indicating that its dividend is sufficiently covered by earnings. Analysts expect Perrigo to earn $3.06 per share next year, which means the company should continue to be able to cover its $1.10 annual dividend with an expected future payout ratio of 35.9%.
Perrigo Stock Up 2.8 %
Shares of NYSE PRGO opened at $24.81 on Thursday. The company has a debt-to-equity ratio of 0.94, a current ratio of 2.56 and a quick ratio of 1.77. The company’s fifty day simple moving average is $25.06 and its 200 day simple moving average is $26.29. Perrigo has a 12-month low of $23.14 and a 12-month high of $33.46.
Insider Activity at Perrigo
Analyst Ratings Changes
Several analysts have recently commented on PRGO shares. Argus downgraded Perrigo from a “buy” rating to a “hold” rating in a research note on Tuesday, January 14th. Piper Sandler downgraded Perrigo from an “overweight” rating to a “neutral” rating and decreased their price objective for the company from $34.00 to $27.00 in a report on Monday, January 6th. Finally, StockNews.com downgraded shares of Perrigo from a “buy” rating to a “hold” rating in a research report on Wednesday. Four analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $35.00.
Get Our Latest Stock Analysis on PRGO
About Perrigo
Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.
Featured Stories
- Five stocks we like better than Perrigo
- Trading Halts Explained
- Fastenal : Growth Trends, Challenges & Key Investment Insights
- Why Are Stock Sectors Important to Successful Investing?
- 2 Auto Stocks to Let Go and 1 Worth Buying for the Long Haul
- What Does a Stock Split Mean?
- Biogen Stock Is Mutating Into a Value Play
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.